Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study [Phase 3]
Phase 3 trial update for Dyanavel XR extended-release suspension in children with ADHD, completed with results posted.
-
FDA approval · 2019-07-03FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of four amphetamine salts (dextroamphetamine saccharate, amphetamine as…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years [Phase 4]
A Phase 4 pharmacokinetic study of DYANAVEL XR extended-release amphetamine in children aged 4 to 5 years with ADHD has been completed; resu…
-
FDA approval · 2019-06-14FDA Approved: APTENSIO XR — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for APTENSIO XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals L.P.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD [Phase 3]
Phase 3 classroom study of PRC-063 in children aged 6-12 with ADHD has completed and results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder [Phase 4]
Phase 4 trial evaluating the effects of 800 mg Rhodiola Rosea on attention in adults with Attention Deficit Hyperactivity Disorder (ADHD).
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder [Phase 4]
Phase 4 clinical trial update evaluating Rhodiola Rosea in adults with Attention Deficit/Hyperactivity Disorder; current status unknown.
-
FDA approval · 2019-05-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s methylphenidate hydrochloride granules as an original generic drug application.
-
FDA approval · 2019-05-16FDA Approved: JORNAY PM EXTENDED-RELEASE — Supplemental Application (Ironshore Pharmaceuticals Inc.)
FDA approves a supplemental application for Jornay PM Extended-Release (methylphenidate hydrochloride) from Ironshore Pharmaceuticals. The a…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation [Phase 2]
A Phase 2 clinical trial evaluated adding serotonin reuptake inhibitors to stimulant therapy in youth with severe mood dysregulation, with r…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: The Efficacy and Safety of PRC-063 in Adult ADHD Patients [Phase 3]
Phase 3 trial update on PRC-063 for adult ADHD reported completed status with results posted in 2019.
-
FDA approval · 2019-04-30FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc. The approval updates the labe…
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: 12 Month Open Extension of TNS for ADHD. [NA]
A 12-month open extension study of TNS for ADHD has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Four-week Open-trial Extension TNS for ADHD [NA]
Clinical trial update describing a four-week open-trial extension for ADHD (no results detail provided in snippet).
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 [Phase 2, Phase 3]
A completed clinical trial investigating treatment of adult ADHD in methadone-maintained patients across Phase 2 and Phase 3.
-
FDA approval · 2019-04-22FDA Approved: MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR — Original Application (SpecGx LLC)
FDA approved the original ANDA for MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR, a generic extended-release amphetamine formulation…
-
FDA approval · 2019-04-17FDA Approved: AMPHETAMINE SULFATE — Original Application (Aurolife Pharma, LLC)
FDA approved the original application for Amphetamine Sulfate from Aurolife Pharma, LLC, expanding generic options for this stimulant medica…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Trigeminal Nerve Stimulation for ADHD [NA]
Clinical trial update on trigeminal nerve stimulation for ADHD has completed; results posted in 2019.
-
CLINICAL_TRIALS research · 2019-04-03Clinical Trial Update: Atomoxetine in Veterans With Comorbid ADHD/PTSD [Phase 4]
Phase 4 trial update evaluating atomoxetine in veterans with comorbid ADHD and PTSD; study completed with posted results.
-
CLINICAL_TRIALS research · 2019-03-18Clinical Trial Update: Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD [NA]
A completed clinical trial evaluating educating and supporting primary care providers in implementing evidence-based practices for ADHD.
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder) [Phase 3]
Phase 3 trial assessing the efficacy and safety of a combination of ginkgo extract and ginseng extract for children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD [Phase 3]
A Phase 3 trial comparing a combination of Ginkgo extract and Ginseng extract (YY-162) for ADHD in children has completed, focusing on effic…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Effects of CO-OP Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder [NA]
Completed clinical trial evaluating the CO-OP approach on activity and participation in Brazilian children with developmental coordination d…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Software Treatment for Actively Reducing Severity of ADHD - Follow Up [NA]
Update on a completed clinical trial evaluating a software-based digital treatment for reducing ADHD symptoms; results were posted in Februa…
-
FDA approval · 2019-02-05FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for DYANAVEL XR (amphetamine) from NextWave Pharmaceuticals, expanding its approved use under th…